TY - JOUR
T1 - Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population
AU - Sawada, Genta
AU - Niida, Atsushi
AU - Uchi, Ryutaro
AU - Hirata, Hidenari
AU - Shimamura, Teppei
AU - Suzuki, Yutaka
AU - Shiraishi, Yuichi
AU - Chiba, Kenichi
AU - Imoto, Seiya
AU - Takahashi, Yusuke
AU - Iwaya, Takeshi
AU - Sudo, Tomoya
AU - Hayashi, Tomoatsu
AU - Takai, Hiroki
AU - Kawasaki, Yoshihiro
AU - Matsukawa, Takashi
AU - Eguchi, Hidetoshi
AU - Sugimachi, Keishi
AU - Tanaka, Fumiaki
AU - Suzuki, Hiromichi
AU - Yamamoto, Ken
AU - Ishii, Hideshi
AU - Shimizu, Makiko
AU - Yamazaki, Hiroshi
AU - Yamazaki, Makoto
AU - Tachimori, Yuji
AU - Kajiyama, Yoshiaki
AU - Natsugoe, Shoji
AU - Fujita, Hiromasa
AU - Mafune, Kenichi
AU - Tanaka, Yoichi
AU - Kelsell, David P.
AU - Scott, Claire A.
AU - Tsuji, Shoji
AU - Yachida, Shinichi
AU - Shibata, Tatsuhiro
AU - Sugano, Sumio
AU - Doki, Yuichiro
AU - Akiyama, Tetsu
AU - Aburatani, Hiroyuki
AU - Ogawa, Seishi
AU - Miyano, Satoru
AU - Mori, Masaki
AU - Mimori, Koshi
N1 - Funding Information:
This research used computational resources of the K computer provided by the RIKEN Advanced Institute for Computational Science through the HPCI System Research project (Project ID: hp140230). Computational time was also provided by the Supercomputer System, Human Genome Center, Institute of Medical Science, University of Tokyo. The authors would like to thank Prof Keitaro Matsuo for the insightful discussions, Prof Kay Huebner for help in editing the manuscript, and Ms F. Todokoro, Ms K. Imamura, Ms T. Horiuchi, and Ms Y. Ishikawa for providing technical assistance with the next-generation sequencing. In addition, the authors would like to thank Ms T. Shimo-oka, Ms M. Kasagi, Ms T. Kohno, Ms K. Oda, Ms M. Aoyagi, and Ms T. Kawano for providing assistance with molecular biology procedures.
Publisher Copyright:
© 2016 AGA Institute.
PY - 2016/5/1
Y1 - 2016/5/1
N2 - Background & Aims Esophageal squamous cell carcinoma (ESCC) is the predominant form of esophageal cancer in Japan. Smoking and drinking alcohol are environmental risk factors for ESCC, whereas single nucleotide polymorphisms in ADH1B and ALDH2, which increase harmful intermediates produced by drinking alcohol, are genetic risk factors. We conducted a large-scale genomic analysis of ESCCs from patients in Japan to determine the mutational landscape of this cancer. Methods We performed whole-exome sequence analysis of tumor and nontumor esophageal tissues collected from 144 patients with ESCC who underwent surgery at 5 hospitals in Japan. We also performed single-nucleotide polymorphism array-based copy number profile and germline genotype analyses of polymorphisms in ADH1B and ALDH2. Polymorphisms in CYP2A6, which increase harmful effects of smoking, were analyzed. Functions of TET2 mutants were evaluated in KYSE410 and HEK293FT cells. Results A high proportion of mutations in the 144 tumor samples were C to T substitution in CpG dinucleotides (called the CpG signature) and C to G/T substitutions with a flanking 5′ thymine (called the APOBEC signature). Based on mutational signatures, patients were assigned to 3 groups, which associated with environmental (drinking and smoking) and genetic (polymorphisms in ALDH2 and CYP2A6) factors. Many tumors contained mutations in genes that regulate the cell cycle (TP53, CCND1, CDKN2A, FBXW7); epigenetic processes (MLL2, EP300, CREBBP, TET2); and the NOTCH (NOTCH1, NOTCH3), WNT (FAT1, YAP1, AJUBA) and receptor-tyrosine kinase-phosphoinositide 3-kinase signaling pathways (PIK3CA, EGFR, ERBB2). Mutations in EP300 and TET2 correlated with shorter survival times, and mutations in ZNF750 associated with an increased number of mutations of the APOBEC signature. Expression of mutant forms of TET2 did not increase cellular levels of 5-hydroxymethylcytosine in HEK293FT cells, whereas knockdown of TET2 increased the invasive activity of KYSE410 ESCC cells. Computational analyses associated the mutations in NFE2L2 we identified with transcriptional activation of its target genes. Conclusions We associated environmental and genetic factors with base substitution patterns of somatic mutations and provide a registry of genes and pathways that are disrupted in ESCCs. These findings might be used to design specific treatments for patients with esophageal squamous cancers.
AB - Background & Aims Esophageal squamous cell carcinoma (ESCC) is the predominant form of esophageal cancer in Japan. Smoking and drinking alcohol are environmental risk factors for ESCC, whereas single nucleotide polymorphisms in ADH1B and ALDH2, which increase harmful intermediates produced by drinking alcohol, are genetic risk factors. We conducted a large-scale genomic analysis of ESCCs from patients in Japan to determine the mutational landscape of this cancer. Methods We performed whole-exome sequence analysis of tumor and nontumor esophageal tissues collected from 144 patients with ESCC who underwent surgery at 5 hospitals in Japan. We also performed single-nucleotide polymorphism array-based copy number profile and germline genotype analyses of polymorphisms in ADH1B and ALDH2. Polymorphisms in CYP2A6, which increase harmful effects of smoking, were analyzed. Functions of TET2 mutants were evaluated in KYSE410 and HEK293FT cells. Results A high proportion of mutations in the 144 tumor samples were C to T substitution in CpG dinucleotides (called the CpG signature) and C to G/T substitutions with a flanking 5′ thymine (called the APOBEC signature). Based on mutational signatures, patients were assigned to 3 groups, which associated with environmental (drinking and smoking) and genetic (polymorphisms in ALDH2 and CYP2A6) factors. Many tumors contained mutations in genes that regulate the cell cycle (TP53, CCND1, CDKN2A, FBXW7); epigenetic processes (MLL2, EP300, CREBBP, TET2); and the NOTCH (NOTCH1, NOTCH3), WNT (FAT1, YAP1, AJUBA) and receptor-tyrosine kinase-phosphoinositide 3-kinase signaling pathways (PIK3CA, EGFR, ERBB2). Mutations in EP300 and TET2 correlated with shorter survival times, and mutations in ZNF750 associated with an increased number of mutations of the APOBEC signature. Expression of mutant forms of TET2 did not increase cellular levels of 5-hydroxymethylcytosine in HEK293FT cells, whereas knockdown of TET2 increased the invasive activity of KYSE410 ESCC cells. Computational analyses associated the mutations in NFE2L2 we identified with transcriptional activation of its target genes. Conclusions We associated environmental and genetic factors with base substitution patterns of somatic mutations and provide a registry of genes and pathways that are disrupted in ESCCs. These findings might be used to design specific treatments for patients with esophageal squamous cancers.
UR - http://www.scopus.com/inward/record.url?scp=84964343756&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84964343756&partnerID=8YFLogxK
U2 - 10.1053/j.gastro.2016.01.035
DO - 10.1053/j.gastro.2016.01.035
M3 - Article
C2 - 26873401
AN - SCOPUS:84964343756
SN - 0016-5085
VL - 150
SP - 1171
EP - 1182
JO - Gastroenterology
JF - Gastroenterology
IS - 5
ER -